➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Baxter
Colorcon
McKinsey
AstraZeneca

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TAK-475


Email this page to a colleague

« Back to Dashboard

Clinical Trials for TAK-475

Trial ID Title Status Sponsor Phase Summary
NCT00034281 ↗ Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 Completed Takeda Phase 1 The purpose of this study is to investigate a safe dose of TAK-165, once daily (QD), in patients with HER2-tumor expression.
NCT00143611 ↗ Efficacy & Safety of Resatorvid in Adults With Severe Sepsis Completed Takeda Phase 3 The purpose of this study is to determine the optimal dose of Resatorvid for reducing 28-day all-cause mortality in subjects with severe sepsis.
NCT00143663 ↗ Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol Completed Takeda Phase 3 The purpose of this study is to determine if patients with elevated cholesterol, but not taking any other lipid medication, could lower their cholesterol with administration of lapaquistat acetate, once daily (QD).
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for TAK-475

Condition Name

Condition Name for
Intervention Trials
Healthy Volunteers 44
Hypertension 17
Prostate Cancer 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Diabetes Mellitus 30
Hypertension 27
Diabetes Mellitus, Type 2 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TAK-475

Trials by Country

Trials by Country for
Location Trials
Japan 598
Canada 94
China 90
United Kingdom 70
Mexico 63
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
Texas 90
California 88
Florida 72
Ohio 69
Pennsylvania 60
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TAK-475

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 4 4
Phase 3 113
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 151
Not yet recruiting 103
Recruiting 50
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TAK-475

Sponsor Name

Sponsor Name for
Sponsor Trials
Takeda 254
Millennium Pharmaceuticals, Inc. 78
National Cancer Institute (NCI) 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 345
Other 42
NIH 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Medtronic
McKesson
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.